A study to find out the relationship between insulin resistance and hypertension
DOI:
https://doi.org/10.18203/2349-3933.ijam20173731Keywords:
Correlation, Hypertension, Insulin resistanceAbstract
Background: Insulin resistance is the essential defect in the development of type 2 diabetes mellitus, hypertension and cardiovascular diseases. The aim of the present study was to evaluate the correlation between insulin resistance, metabolic syndrome and their associated factors in hypertensive patients.
Methods: This comparative study was conducted on 100 patients who attended to the Department of Medicine, NSCB Medical College, Jabalpur, Madhya Pradesh, India. 50 patients of both sexes having essential hypertension were participated in the study and considered as hypertensive group. Other healthy 50 patients of similar sex and age group were studied as control group (normotensive) for comparison. Insulin resistance was estimated by using homeostasis model assessment (HOMA-IR) method.
Results: Mean age of the patients of hypertensive group was 49.79±17.04 years and mean age of normotensive group was 51.94±16.64 years. Male preponderance was observed in both the groups. Out of 50 from each group, 19 (38%) of hypertensive patients and 7 (14%) of normotensive patients had insulin resistance. Metabolic syndrome was noted in 23 (46%) and 10 (20%) cases of hypertensive and normotensive groups respectively and this difference was found to be statistically significant (p=0.01). The mean fasting and post prandial blood sugar levels were almost similar in both groups (p=0.03). Mean total cholesterol levels were significantly lower in hypertensive groups than that of normotensive group (p=0.03). The mean serum insulin levels were high in hypertensive groups than that of normotensive group which was statistically significant (p=0.00). Mean HOMA-IR, waist size and waist hip ratio (WHR) was significantly (p=0.02) higher in hypertensive group than that of control group.
Conclusions: The results of the present study support the strong correlation between insulin resistance and essential hypertension and also confirmed that insulin resistance was the major risk factor of metabolic syndrome.
References
Murray CJL, Lopez AD. Global health statistics: global burden of disease and injury series. Harvard School of Public Health, Boston. 1996:23-6.
The World Health Organization. Study group on diabetes mellitus making a difference. World Health Organi-zation, Geneva; 1999.
Reaven GM. Role of insulin resistance in human disease (Syndrome X): an expanded definition. Annu Rev Med. 1993;44:121-31.
Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-7.
Mbanya JC, Thomas TH, Wilkinson R, Alberti KG, Taylor R. Hypertension and hyperinsulinemia: a relation in diabetes but not essential hypertension. Lancet. 1988;1:733-4.
Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 1991;324:733-9.
Reddy KS. Hypertension control in developing coun-tries. Generic issues. J Hum Hypertens. 1996;10:33-8.
Stern MP, Knapp JA, Hazuda HP, Haffner SM, Patterson JK, Mitchell BD. Genetic and environmental determinants of type II diabetes in Mexican Americans. Is there a “descending limb” to the modernization / diabetes relation-ship? Diabetes Care. 1991;14:649-54.
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates and projections. Diabetes Care. 1998;21:1414-31.
Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet. 1980;1:1373-6.
The DECODE study group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet. 1999;354:617-21.
Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H. Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11-years follow-up. Diabetologia. 1996;39:1577-83.
Ford ES, Gile WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. In: Gan D, editor. Diabetes Atlas. International Diabetes Federation. 3rd ed. Belgium: International Diabetes Federation; 2006:15-103.
Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41(6):715-22.
Sinha S, Akhter QS, Banik S, Islam MK, Haque M. Correlation Study of Insulin Resistance and Essential Hypertension among Bangladeshi Male Volunteers. JYP. 2015;7(3):200-5.
Garcia-Puig J, Ruilope LM, Luque M, Fernandez J, Ortega R, Dal-Re R. AVANT Study Group Investigators. Glucose metabolism in patients with essential hypertension. Am J Med. 2006;119(4):318-26.
